When contextualized with the developments across all genitourinary [GU] malignancies, especially renal cell carcinoma and ...
AURORA: A single arm, multicentre, phase II clinical trial of atezolizumab immunotherapy for advanced squamous cell carcinoma of the bladder and urinary tract. Sasanlimab in combination with bacillus ...
Genitourinary cancers include prostate, bladder, kidney, and testicular cancers, with diagnosis involving imaging and biopsy. Treatment is personalized, involving surgery, radiation, chemotherapy, ...
Cross-referencing protocols/registries with publications revealed substantial attrition from planned QoL endpoints to disseminated results across prostate, kidney, and bladder cancer trials. Selective ...
FORT MYERS, Fla., Feb. 26, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) advances genitourinary cancer treatment through participation at the global ASCO® 2026 ...
Impact of treatment approaches on survival in bulky node-positive penile squamous cell carcinoma: A National Cancer Database analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
Dr. Maluf emphasized that his discussion would focus on penile squamous cell carcinoma and genitourinary basket trials. At ...
The MarketWatch News Department was not involved in the creation of this content. FCS Physicians Present Novel Clinical Trial Findings in Prostate and Urothelial Cancers at the ASCO 2026 Genitourinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results